Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib in methotrexate-naive rheumatoid arthritis
2016-000570-37Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of filgotinib in rheumatoid arthritis (RA) (4 arms), sponsored by Gilead Sciences. Primary endpoint: ACR20 response at Week 24. Started Oct 2016; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2016-000570-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000570-37.